These findings underscore the potential clinical significance of SREBP-2 in assessing COVID-19 severity and its role in the prevention of cytokine storms and lung injury, offering novel prospects for the diagnosis and treatment of COVID-19. The gene discussed is SREBF2; the disease is COVID-19.